ABOUT AbClon
Overview
History
Business Portfolio
Scientific Advisory
Contact Us
ÀÎÀç»ó
º¹¸®ÈÄ»ý/ä¿ëÀýÂ÷
ÀÔ»çÁö¿ø
TECHNOLOGY
Biosynergy Antibody
YPLUS
AffiMab
THERAPEUTIC ANTIBODY
Pipeline
Antibody Drug Industry
ANTIBODY SERVICE
INVESTORS
ÁÖ°¡Á¤º¸
°ø½ÃÁ¤º¸
½ÃÀ庸°í¼
NOTICE
Notice/News
¤ýHome > Community > Notice / News
Total:
120
, page:
2/8
105
ÁÖÁֺе鲲 ¿Ã¸®´Â ¸»¾¸
°ü¸®ÀÚ
2020-09-14
2,157
104
¾ÛŬ·Ð, TNF-¥á ¹× IL-6 ÀúÇØÁ¦ ¡®AM201¡¯ Äڷγª19 Ä¡·á¿ëÀ¸·Î °³¹ß
°ü¸®ÀÚ
2020-08-07
1,510
103
ÀÓ½ÃÁÖÁÖÃÑȸ ¼ÒÁý°ø°í
°ü¸®ÀÚ
2020-07-17
675
102
¾ÛŬ·Ð, Ç÷¾×¾Ï CAR-T ¼¼Æ÷Ä¡·áÁ¦ ±¹³» ƯÇã Ãëµæ
°ü¸®ÀÚ
2020-07-15
745
101
±âÁØÀÏ ¹× ÁÖÁÖ¸íºÎ Æó¼â °ø°í
°ü¸®ÀÚ
2020-07-01
436
100
¾ÛŬ·Ð, Äڷγª19 Ç×ü °³¹ß ¼ÓµµÀü¡¦º¯Á¾ ¹ÙÀÌ·¯½º ÁßÈ´É È®ÀÎ
°ü¸®ÀÚ
2020-06-02
2,506
99
¾ÛŬ·Ð, VEGFR2 °áÇÕ Ç×ü À¯·´ ƯÇã µî·Ï¡¦½Å»ýÇ÷°ü Áúȯ Ÿ±ê
°ü¸®ÀÚ
2020-05-20
555
98
¾ÛŬ·Ð, CAR-T ¼¼Æ÷Ä¡·áÁ¦ ÀÓ»ó¿ë GMP ½Ã¼³ ±¸Ãà
°ü¸®ÀÚ
2020-05-12
582
97
¾ÛŬ·Ð, Äڷγª19 ¹ÙÀÌ·¯½º ¹«·ÂÈ ¾îÇǹٵð È®Á¤
°ü¸®ÀÚ
2020-05-07
653
96
¾ÛŬ·Ð, Äڷγª19 Ç×ü½Å¾à Èĺ¸ µµÃâ ¼º°ø
°ü¸®ÀÚ
2020-04-23
691
95
¾ÛŬ·Ð, °íÇü¾Ï CAR-T Ä¡·áÁ¦(AT501) ÀÓ»ó ¹°Áú µµÃâ ¼º°ø
°ü¸®ÀÚ
2020-04-21
361
94
¾ÛŬ·Ð, CAR-T ÀÓ»ó ¼öÇà ¾÷¹« À§Å¹ °è¾à ü°á
°ü¸®ÀÚ
2020-04-17
337
93
¾ÛŬ·Ð, Äڷγª19 ÀÌÁßÇ×ü ¹× ¾îÇǹٵð ´Üµ¶Ä¡·áÁ¦ °³¹ß Âø¼ö
°ü¸®ÀÚ
2020-04-13
924
92
¾ÛŬ·Ð, Äڷγª19 Ç×üġ·áÁ¦ °³¹ß ½º¿þµ§ HPA¿Í °øµ¿ ´ëÀÀ
°ü¸®ÀÚ
2020-04-07
658
91
¾ÛŬ·Ð, Äڷγª19 °áÇÕ ½Å±Ô Àΰ£Ç×ü ´Ù¼ö µµÃâ ¼º°ú
°ü¸®ÀÚ
2020-03-30
848
1
2
3
4
5
6
7
8
Á¦¸ñ
³»¿ë
±Û¾´ÀÌ